Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06858488 · ClinicalTrials.gov registry record · NA
Bioimpedance for Ortho Trauma
A NA study of Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06858488: Recruiting NA study of Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06858488 is a NA study of Trauma Injury that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 30 participants, below the 499-participant average among 15 other Trauma Injury trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06858488, a NA study of Trauma Injury, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with high-energy extremity trauma will undergo imaging with an EIT device in the Emergency Department, Operating Room, Orthopaedic Clinic, and In-patient hospital rooms. The EIT device is an electrical impedance tomography system.
Primary Outcome
The primary objective of this work is to explore whether changes in impedance measurement associated with EIT are associated with soft tissue injury and readiness for surgical intervention. EIT is a technique which introduces a small amount of electrical current into biologic tissue through an array of electrodes and measures the change in signal to generate images related to the physiology of that tissue.
Conditions Studied
Interventions
- PROCEDURE Extremity Surgery
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-20 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06858488 shows while recruiting
NCT06858488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 499-participant average among 15 other Trauma Injury trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Trauma Injury appearing as the primary indexed condition, and to 1 intervention - of which Extremity Surgery is the first listed.
NCT06858488 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06858488 about?
NCT06858488 is a clinical study titled "Bioimpedance for Ortho Trauma". Patients with high-energy extremity trauma will undergo imaging with an EIT device in the Emergency Department, Operating Room, Orthopaedic Clinic, and In-patient hospital rooms. The EIT device is an electrical impedance tomography system.
What is the current status of trial NCT06858488?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-20. Estimated completion is 2027-06.
What conditions does trial NCT06858488 study?
This clinical trial studies the following conditions: Trauma Injury.
What interventions are being tested in trial NCT06858488?
The interventions under investigation include: Extremity Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06858488?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06858488 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06858488's enrollment target sits among peer trials
30 14th of 15 higher than 2 of 15 other Trauma Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
RECRUITING · NA
-
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
RECRUITING · NA
-
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
RECRUITING · NA
-
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
RECRUITING · NA
-
The Effects of Footplate Stiffness on Foot Loading Within Carbon Fiber Custom Dynamic Orthoses
RECRUITING · NA
-
Using mHealth to Improve Emotional Recovery After Pediatric Injury
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI